Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Research Shows Product Shortens Duration of Common Cold
Randomized, double-blind, placebo-controlled, multi-center study presented at the First International Conference on Natural Products and Molecular Therapy indicates that UMCKA(R) COLDCARE(TM), a proprietary medicine made from Pelargonium sidoides roots, significantly shortens duration and reduces severity of the common cold.
- Research Shows Product Shortens Duration of Common Cold
Randomized, double-blind, placebo-controlled, multi-center study presented at the First International Conference on Natural Products and Molecular Therapy indicates that UMCKA(R) COLDCARE(TM), a proprietary medicine made from Pelargonium sidoides roots, significantly shortens duration and reduces severity of the common cold.
- Research Shows Product Shortens Duration of Common Cold
Randomized, double-blind, placebo-controlled, multi-center study presented at the First International Conference on Natural Products and Molecular Therapy indicates that UMCKA(R) COLDCARE(TM), a proprietary medicine made from Pelargonium sidoides roots, significantly shortens duration and reduces severity of the common cold.
- Research Shows Product Shortens Duration of Common Cold
Randomized, double-blind, placebo-controlled, multi-center study presented at the First International Conference on Natural Products and Molecular Therapy indicates that UMCKA(R) COLDCARE(TM), a proprietary medicine made from Pelargonium sidoides roots, significantly shortens duration and reduces severity of the common cold.
- Research Shows Product Shortens Duration of Common Cold
Randomized, double-blind, placebo-controlled, multi-center study presented at the First International Conference on Natural Products and Molecular Therapy indicates that UMCKA(R) COLDCARE(TM), a proprietary medicine made from Pelargonium sidoides roots, significantly shortens duration and reduces severity of the common cold.
- Calcium and Vitamin D Most Effective for Treatment of Crohn's-related Bone Loss
Study shows that calcium and vitamin D treatment alone can improve bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year; addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.
- Calcium and Vitamin D Most Effective for Treatment of Crohn's-related Bone Loss
Study shows that calcium and vitamin D treatment alone can improve bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year; addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.
- Calcium and Vitamin D Most Effective for Treatment of Crohn's-related Bone Loss
Study shows that calcium and vitamin D treatment alone can improve bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year; addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.
- Calcium and Vitamin D Most Effective for Treatment of Crohn's-related Bone Loss
Study shows that calcium and vitamin D treatment alone can improve bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year; addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.
- Calcium and Vitamin D Most Effective for Treatment of Crohn's-related Bone Loss
Study shows that calcium and vitamin D treatment alone can improve bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year; addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.
- Calcium and Vitamin D Most Effective for Treatment of Crohn's-related Bone Loss
Study shows that calcium and vitamin D treatment alone can improve bone mineral density (BMD) in Crohn's patients by 3 to 4 percent per year; addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.
- U.S. Department of Defense University and Humanetics to Co-Develop Multiple Compounds
Focus of new agreement is to develop and commercialize nutritional supplements and drugs that show promise in supporting and protecting the immune system against challenges from exposure to radiation
- U.S. Department of Defense University and Humanetics to Co-Develop Multiple Compounds
Focus of new agreement is to develop and commercialize nutritional supplements and drugs that show promise in supporting and protecting the immune system against challenges from exposure to radiation
- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort)
Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat.
- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort)
Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat.
- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort)
Researchers note that half of those given St. John's wort for six weeks in this randomised double blind, reference controlled trial, reported an improvement in their symptoms, versus one third of those who took Seroxat.
- Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis
Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July.
- Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis
Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July.
- Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis
Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July.
- Advitech Completes Recruitment For Second Clinical Study on Oral Treatment For Psoriasis
Eighty-four patients with mild to moderate psoriasis have been recruited; treatment phase is expected to be completed by the end of June and results should be made available in July.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- St. John’s wort as Effective as Popular Prescription Anti-Depressant
Organization comments on study published Friday February 13th in British Medical Journal.
- St. John’s wort as Effective as Popular Prescription Anti-Depressant
Organization comments on study published Friday February 13th in British Medical Journal.
- 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies
Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis.
- 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies
Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis.
- 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies
Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis.
- 14-Center Study Confirms Effectiveness of Aller-7 in 545 People With Airborne Allergies
Multicenter clinical trial spanning three years and involving 545 patients in 14 clinical centers confirms the safety and efficacy of Aller-7(R) in people with allergic rhinitis.
- Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases
Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases.
- Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases
Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases.
- Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases
Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases.
- Advitech and CHUL Research Center to Test XP-828L For the Treatment of Inflammatory Bowel Diseases
Advitech and CHUL Research Center, CHULRC (CHUQ) will carry out a research project to assess the potential of XP-828L, a purified milk protein fraction with a patented growth factor composition, for treatment of inflammatory bowel diseases.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Study Results Show Efficacy of Bioforce’s Prostasan
Swiss study of 364 men indicates reduction of symptoms.
- Study Results Show Efficacy of Bioforce’s Prostasan
Swiss study of 364 men indicates reduction of symptoms.
- Study Results Show Efficacy of Bioforce’s Prostasan
Swiss study of 364 men indicates reduction of symptoms.
- Study Results Show Efficacy of Bioforce’s Prostasan
Swiss study of 364 men indicates reduction of symptoms.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- Scientific Experts Meet to Discuss Safety and Benefits of Vitamin E
Group concluded that antioxidant supplements are safe and appear to confer a health benefit in certain individuals; Future research in well-defined populations with both clinical and biomarker end-points needs to be undertaken.
- COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes
Company announces partnership project
to investigate the potential use of COLD-fX(R) as a "standard of care" for the
prevention of upper respiratory infections in Canadian nursing homes.
- COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes
Company announces partnership project
to investigate the potential use of COLD-fX(R) as a "standard of care" for the
prevention of upper respiratory infections in Canadian nursing homes.
- COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes
Company announces partnership project
to investigate the potential use of COLD-fX(R) as a "standard of care" for the
prevention of upper respiratory infections in Canadian nursing homes.
- COLD-fX(R) to be Studied as New Way to Protect Seniors from Influenza in Canadian Nursing Homes
Company announces partnership project
to investigate the potential use of COLD-fX(R) as a "standard of care" for the
prevention of upper respiratory infections in Canadian nursing homes.
- New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress
German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury.
- New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress
German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury.
- New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress
German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury.
- New Study Shows GliSODin(R) Inhibits DNA Damage Due to Ischemia-reperfusion Induced Oxidative Stress
German researchers conclude that pretreatment with GliSODin inhibits oxidative DNA damage related to induced ischemia-reperfusion injury.
- Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients.
- Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients.
- Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients.
- Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Study shows that folate and vitamin B12 reduce risk of hip fracture in elderly patients.
- Vitamin D Injections May Significantly Improve Survival in Dialysis Patients
Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies.
- Vitamin D Injections May Significantly Improve Survival in Dialysis Patients
Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies.
- Vitamin D Injections May Significantly Improve Survival in Dialysis Patients
Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies.
- Vitamin D Injections May Significantly Improve Survival in Dialysis Patients
Study to be published in the April Journal of the American Society of Nephrology, shows that 76% of those dialysis patients receiving any form of activated vitamin D were still alive at the end of a two-year period, compared with 59% of those not receiving the therapy; researchers suggest more studies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
BOHEMIA, N.Y., Feb 24, 2005 /PRNewswire via COMTEX/ -- Folic acid, a B-vitamin that is necessary for proper cell growth and recognized for its ability to reduce the risk of birth defects, has been shown to have another significant health benefit for women: decreasing the incidence of hypertension. The importance of taking folic acid was elevated in 1992 when the United States Public Health Service recommended that all women of childbearing years should take 400 micrograms (0.4 mg) of folic acid daily to prevent having a pregnancy affected by a neural tube defect. Today, new research is indicating that folic acid can also help prevent other birth defects, such as cleft lip and cleft palate. In addition, according to researchers from Brigham & Women's Hospital and Harvard Medical School, higher folic acid intake from food and supplements appears to reduce the risk of high blood pressure. The study was published in the Jan. 19 issue of The Journal of the American Medical Association (JAMA) (293, 3:320-9, 2005) (http://jama.ama-assn.org). The recommended dosage of folic acid can be obtained by eating a variety of foods as part of a healthy diet, including dark, leafy green vegetables, orange juice, strawberries, legumes and grains. Since sometimes it is hard to ensure getting the right amount of this nutrient in our daily diets, taking a dietary supplement such as Sundown(R) Folic Acid is the simplest way to ensure the daily recommended dosage is reached. It is available in 400 mcg and 800 mcg dosages -- making it easy for consumers to promote their health and wellness.
The many benefits associated with folic acid intake, including the recently published hypertension risk reduction study and the well-documented prevention of neural tube defects, are showing promise for women's health, but the widespread impact of low-carbohydrate diets may negate some of these benefits. For example, most low-carb diets eliminate foods, such as grains, rice and pastas, that are sources of B-vitamins. As a result, women might not be aware they are deficient in folic acid and at risk for birth defects while in their childbearing years. If one is devoted to a low-carb lifestyle, taking 400 mcg to 800 mcg of Sundown Folic Acid daily is recommended.
About the Brigham & Women's Hospital and Harvard Medical School Study
John P. Forman, M.D., of Brigham and Women's Hospital and Harvard Medical School, Boston and colleagues analyzed data from two studies (93,803 younger women aged 27 to 44 years in the Nurses' Health Study II [1991-1999] and 62,260 older women aged 43 to 70 years in the Nurses' Health Study I [1990- 1998]). The participants did not have a history of hypertension. Baseline information on dietary folate and supplemental folic acid intake was derived from food frequency questionnaires and was updated every four years for a total of eight years. The purpose of this study was to determine whether higher folic acid intake is associated with a lower risk of hypertension.
Results: The researchers found that younger women who consumed at least 1,000 micrograms per day of total folic acid (dietary plus supplemental) had a 46 percent decreased risk of hypertension, compared with those who consumed less than 200 micrograms a day of total folic acid. Older women with high total folic acid intake also had an 18 percent reduced risk of hypertension. In the study, researchers found that the women who only consumed folic acid from food, rather than supplements, had difficulty attaining high enough levels to lower their blood pressure.
As more studies unfold on folic acid, this essential B-vitamin is demonstrating healthy heart and circulation benefits by helping to maintain proper levels of homocysteine in the blood.* Women of all ages can promote their health and well-being by taking at least 400 micrograms of folic acid each day and by following the new 2005 Dietary Guidelines for Americans ( http://www.health.gov/dietaryguidelines ) to ensure they are eating a variety of foods.
Visit http://www.sundownnutrition.com to learn about Sundown Folic Acid in 400 mcg and 800 mcg dosages; and Sundown Folic Acid Xtra, which is enhanced with B-2, B-6, B-12 and choline.
About Rexall Sundown
Rexall Sundown, a trusted, long-standing name in the nutritional industry, is a subsidiary of NBTY, Inc. (NTY), a leading vertically integrated manufacturer and distributor of high-quality, value-priced nutritional supplements in the United States and throughout the world. The company markets approximately 1,500 products under several brands. Rexall Sundown has consistently been awarded the highest quality rating of its facilities by Shuster Laboratories, Inc., a leading independent quality compliance auditing firm used by pharmaceutical and supplement companies.
* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. |